Yüklüyor......
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutations
RAF inhibitor monotherapy is ineffective in BRAF-mutant colorectal cancer (CRC) but RAF inhibitor combinations have demonstrated improved efficacy, likely through superior suppression of MAPK signaling. The first identified mechanisms of acquired resistance to these combinations all promote MAPK rea...
Kaydedildi:
| Yayımlandı: | Mol Cell Oncol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4845183/ https://ncbi.nlm.nih.gov/pubmed/27308562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2015.1048405 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|